Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, and immunology, through a collaboration that could generate more than $15.2 ...
Terry Flotte, MD, steps down as ASGCT president at the end of this week. In this exclusive interview, Terry shares the ...
Researchers say findings may have relevance to understanding cell biological pathways that contribute to nerve repair after injury or neurodegeneration.
One of the winners of the 2026 ASGCT Catalyst Award, Kiran Musunuru, MD, PhD, delivered a sobering lecture on the legacy of the Baby KJ story and the real-world discussions with the FDA to streamline ...
A 3D-printed example of the kind of antibiotic peptide the researchers generated using AI, held in a server room at the University of Pennsylvania. [Sylvia Zhang, Penn Engineering] Antibiotic ...
Sickle cell warrior Victoria Gray, the first patient to enroll in the Casgevy gene editing trial, shared some highs and lows ...
With faster and more affordable transcriptomic technologies, high-throughput RNA-seq can now be incorporated into oligo ...
Throughout this three-part webinar series, experts from USP and industry will share first-hand experiences, case studies, and ...
New POLARIS Phase I/II data presented at ASGCT show ETX101 gene therapy reducing seizures and improving neurodevelopment in ...
Genomics and Harvard University have sued Element Biosciences, alleging that Element’s AVITI24™ multiomics platform, Teton ...
A Phase I/II clinical trial shows that a stem cell transplant that removes CD33 from donor cells using CRISPR can prevent ...
The EvoLVcell stable producer cell line generation platform reportedly reduces variability and produces fewer impurities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results